Want to see SE:SYNACT full AI Analyst Report?
Ap1189, 100 Mg
Respiratory Viral Infection
Phase II
Recruiting
A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Participants With Respiratory Insufficiency Expected to be Caused by Infection With Respiratory Viruses
Jun 02, 2026
―
Ap1189, 60 Mg, Ap1189, 80 Mg, Ap1189, 100 Mg
Rheumatoid Arthritis
Phase II
Completed
A Dose-range Study of the Safety and Efficacy of Treatment in Adult Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate
Oct 31, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does SynAct Pharma AB (SYNACT) have in its pipeline
SYNACT is currently developing the following drugs: Ap1189, 100 Mg, Ap1189, 100 Mg, Ap1189, 40 Mg, Ap1189, 70 Mg, Ap1189, 60 Mg, Ap1189, 80 Mg, Ap1189, 100 Mg. These drug candidates are in various stages of clinical development as the company works toward FDA approval.